(Q38211727)

31 August 2017

title

Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies (English)

1 reference

31 August 2017

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827845%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Bárbara Gomes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827845%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Manuel Coelho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827845%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Maria do Carmo Pereira

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827845%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Sandra Rocha

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827845%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

1 April 2014

1 reference

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827845%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827845%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827845%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

709-722

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827845%20AND%20SRC:MED&resulttype=core&format=json

Liposomes and nanotechnology in drug development: focus on neurological targets

3 June 2020

cites work

1 reference

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid

21 January 2018

1 reference

Gene therapy for Parkinson's disease: an approach to the prevention or palliation of levodopa-associated motor complications

21 January 2018

1 reference

Parkinson's disease: from molecular pathways in disease to therapeutic approaches

21 January 2018

1 reference

Transport of drugs across the blood-brain barrier by nanoparticles.

21 January 2018

1 reference

Strategy for effective brain drug delivery.

21 January 2018

1 reference

OX26 modified hyperbranched polyglycerol-conjugated poly(lactic-co-glycolic acid) nanoparticles: synthesis, characterization and evaluation of its brain delivery ability.

21 January 2018

1 reference

Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier

21 January 2018

1 reference

Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier

21 January 2018

1 reference

The role of the blood-CNS barrier in CNS disorders and their treatment

21 January 2018

1 reference

Blood-brain barrier alterations in ageing and dementia

21 January 2018

1 reference

Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease

21 January 2018

1 reference

Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: a microdialysis study

21 January 2018

1 reference

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

21 January 2018

1 reference

Drug targeting to the brain.

21 January 2018

1 reference

Recovery and purification process development for monoclonal antibody production

21 January 2018

1 reference

Bioavailability and transport of peptides and peptide drugs into the brain

21 January 2018

1 reference

In vitro and in vivo evaluation of lactoferrin-conjugated liposomes as a novel carrier to improve the brain delivery.

21 January 2018

1 reference

Drug targeting to the brain

21 January 2018

1 reference

Electrical resistance of brain microvascular endothelium.

21 January 2018

1 reference

Electrical resistance of a capillary endothelium

21 January 2018

1 reference

Functional expression and localization of P-glycoprotein at the blood brain barrier

21 January 2018

1 reference

In situ localization of P-glycoprotein (ABCB1) in human and rat brain

21 January 2018

1 reference

The blood-brain barrier and cancer: transporters, treatment, and Trojan horses

21 January 2018

1 reference

Drug resistance in brain diseases and the role of drug efflux transporters.

21 January 2018

1 reference

Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection

21 January 2018

1 reference

The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system

21 January 2018

1 reference

Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia

21 January 2018

1 reference

Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1).

21 January 2018

1 reference

Multidrug resistance-associated proteins: expression and function in the central nervous system

21 January 2018

1 reference

The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier

21 January 2018

1 reference

Drug and gene delivery to the brain: the vascular route

21 January 2018

1 reference

Modulation of drug transporters at the blood-brain barrier

21 January 2018

1 reference

Transferrin receptor on endothelium of brain capillaries

21 January 2018

1 reference

Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier

21 January 2018

1 reference

Biodegradable polymeric nanoparticles based drug delivery systems

21 January 2018

1 reference

Preparation and characterization of protein C-loaded PLA nanoparticles

21 January 2018

1 reference

PLGA-based nanoparticles: an overview of biomedical applications.

21 January 2018

1 reference

Nanoparticles in cancer therapy and diagnosis

21 January 2018

1 reference

Liposomes for brain delivery

21 January 2018

1 reference

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

21 January 2018

1 reference

Affinity liposomes in vivo: factors influencing target accumulation

21 January 2018

1 reference

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

21 January 2018

1 reference

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

21 January 2018

1 reference

Liposomes for the sustained drug release in vivo

21 January 2018

1 reference

Drug transport to brain with targeted liposomes

21 January 2018

1 reference

Recent advances with liposomes as pharmaceutical carriers

21 January 2018

1 reference

Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials

21 January 2018

1 reference

Advantages of liposomal delivery systems for anthracyclines

21 January 2018

1 reference

New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?

21 January 2018

1 reference

Liposomal drug delivery systems: an update review.

21 January 2018

1 reference

Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier

21 January 2018

1 reference

Controlled ring-opening polymerization of lactide and glycolide

21 January 2018

1 reference

Concepts and practices used to develop functional PLGA-based nanoparticulate systems

21 January 2018

1 reference

Continuous cultures of fused cells secreting antibody of predefined specificity

21 January 2018

1 reference

Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery

21 January 2018

1 reference

High transcytosis of melanotransferrin (P97) across the blood-brain barrier

21 January 2018

1 reference

Characteristics of compounds that cross the blood-brain barrier

21 January 2018

1 reference

Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders

21 January 2018

1 reference

A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier

21 January 2018

1 reference

Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier.

21 January 2018

1 reference

Blood-brain barrier transport of reduced folic acid

21 January 2018

1 reference

Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles

21 January 2018

1 reference

Brain drug delivery of small molecules using immunoliposomes

21 January 2018

1 reference

Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.

21 January 2018

1 reference

Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat.

21 January 2018

1 reference

In vivo labeling of brain capillary endothelial cells after intravenous injection of monoclonal antibodies targeting the transferrin receptor

21 January 2018

1 reference

Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier.

21 January 2018

1 reference

Immunohistochemical localization of the murine transferrin receptor (TfR) on blood-tissue barriers using a novel anti-TfR monoclonal antibody.

21 January 2018

1 reference

Expression of transferrin receptor on murine hematopoietic progenitors

21 January 2018

1 reference

Mouse mammary tumor virus uses mouse but not human transferrin receptor 1 to reach a low pH compartment and infect cells

21 January 2018

1 reference

Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles

21 January 2018

1 reference

Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate

21 January 2018

1 reference

Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse

21 January 2018

1 reference

PEGylated immunoliposomes directed against brain astrocytes

21 January 2018

1 reference

Antibody targeted gene transfer to endothelium.

21 January 2018

1 reference

Immunoconjugates and long circulating systems: origins, current state of the art and future directions

21 January 2018

1 reference

Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes

21 January 2018

1 reference

Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system.

21 January 2018

1 reference

Noninvasive gene targeting to the brain

21 January 2018

1 reference

Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line

21 January 2018

1 reference

Targeting the ischemic penumbra

21 January 2018

1 reference

Chitosan enhances the stability and targeting of immuno-nanovehicles to cerebro-vascular deposits of Alzheimer's disease amyloid protein

21 January 2018

1 reference

Binding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery

21 January 2018

1 reference

Targeting the insulin receptor: nanoparticles for drug delivery across the blood-brain barrier (BBB).

21 January 2018

1 reference

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).

21 January 2018

1 reference

Fluorescence-labeled immunomicelles: preparation, in vivo biodistribution, and ability to cross the blood-brain barrier

21 January 2018

1 reference

Anti-Aβ-MAb and dually decorated nanoliposomes: effect of Aβ1-42 peptides on interaction with hCMEC/D3 cells

21 January 2018

1 reference

Biotinylated proteins as molecular weight standards on Western blots

21 January 2018

1 reference

Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes

21 January 2018

1 reference

Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer

21 January 2018

1 reference

Passive and active drug targeting: drug delivery to tumors as an example

21 January 2018

1 reference

Absence of toxicity of chronic weekly intravenous gene therapy with pegylated immunoliposomes

21 January 2018

1 reference

Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions

21 January 2018

1 reference

Characterization and distribution of transferrin receptors in the rat brain.

21 January 2018

1 reference

Rapid transferrin efflux from brain to blood across the blood-brain barrier

21 January 2018

1 reference

Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties

21 January 2018

1 reference

PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect

21 January 2018

1 reference

Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers.

21 January 2018

1 reference

Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan

21 January 2018

1 reference

Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice

21 January 2018

1 reference

Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid beta peptide-capturing and plaque-binding monoclonal antibodies

21 January 2018

1 reference

Selective contrast enhancement of individual Alzheimer's disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar Abeta42 for magnetic resonance molecular imaging

21 January 2018

1 reference

Nanotechnological advances for the delivery of CNS therapeutics

21 January 2018

1 reference

Targeting of skeletal muscle in vitro using biotinylated immunoliposomes

21 January 2018

1 reference

Liposome technology for industrial purposes

21 January 2018

1 reference

Vector-mediated drug delivery to the brain

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/NNM.14.27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827845%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference